Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 928K
2: EX-4.5 Form of Stock Certificate HTML 24K
3: EX-10.50 Lease HTML 414K
4: EX-10.51 Material Contracts HTML 74K
5: EX-10.52 Second Amendment to Lease HTML 52K
6: EX-10.53 Third Amendment to Lease HTML 115K
7: EX-10.58 Executive Employment Agreement HTML 90K
8: EX-10.59 Separation and Release Agreement HTML 58K
9: EX-10.60 Consultant Agreement HTML 59K
10: EX-10.61 Employment Offer Letter HTML 32K
11: EX-10.62 Supply Agreement HTML 246K
12: EX-21.1 Subsidiaries List HTML 25K
13: EX-23.1 Consent of Marcum LLP HTML 29K
14: EX-31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) HTML 31K
Certifications Section 302 of the Sarbanes-Oxly
Act of 2002
15: EX-31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) HTML 31K
Certifications Section 302 of the Sarbanes-Oxly
Act of 2002
16: EX-32.1 Certificate Pursuant to Section 18 U.S.C. Pursuant HTML 28K
to Section 906 of the Sarbanes-Oxley Act of 2002
23: R1 Document and Entity Information HTML 54K
24: R2 Consolidated Balance Sheets HTML 107K
25: R3 Consolidated Balance Sheets (Parenthetical) HTML 47K
26: R4 Consolidated Statements of Operations HTML 87K
27: R5 Consolidated Statement of Stockholders' Equity HTML 68K
28: R6 Consolidated Statements of Cash Flows HTML 130K
29: R7 Nature of Business and Liquidity HTML 31K
30: R8 Significant Accounting Policies HTML 75K
31: R9 Loss Per Share Applicable to Common Stockholders HTML 34K
32: R10 Intangible Assets HTML 34K
33: R11 Leasehold Improvements and Equipment HTML 34K
34: R12 Capitalized Lease Obligations HTML 32K
35: R13 Line of Credit HTML 30K
36: R14 Income Taxes HTML 47K
37: R15 Related Party Transactions HTML 46K
38: R16 Contract Assets and Contract Liabilities HTML 41K
39: R17 Discontinued Operations HTML 65K
40: R18 Share-Based Compensation HTML 93K
41: R19 Stock Issuance HTML 30K
42: R20 Warrants HTML 35K
43: R21 Commitments and Contingencies HTML 62K
44: R22 Business Segmentation and Geographical HTML 129K
Distribution
45: R23 Other Expense HTML 30K
46: R24 Significant Accounting Policies (Policies) HTML 131K
47: R25 Significant Accounting Policies (Tables) HTML 40K
48: R26 Loss Per Share Applicable to Common Stockholders HTML 33K
(Tables)
49: R27 Intangible Assets (Tables) HTML 36K
50: R28 Leasehold Improvements and Equipment (Tables) HTML 33K
51: R29 Capitalized Lease Obligations (Tables) HTML 31K
52: R30 Income Taxes (Tables) HTML 45K
53: R31 Related Party Transactions (Tables) HTML 42K
54: R32 Contract Assets and Contract Liabilities (Tables) HTML 41K
55: R33 Discontinued Operations (Tables) HTML 73K
56: R34 Share-Based Compensation (Tables) HTML 88K
57: R35 Warrants (Tables) HTML 37K
58: R36 Commitments and Contingencies (Tables) HTML 38K
59: R37 Business Segmentation and Geographical HTML 101K
Distribution (Tables)
60: R38 Nature of Business and Liquidity (Details HTML 34K
Narrative)
61: R39 Significant Accounting Policies (Details) HTML 29K
62: R40 Significant Accounting Policies (Details 1) HTML 30K
63: R41 Significant Accounting Policies (Details 2) HTML 43K
64: R42 Significant Accounting Policies (Details HTML 37K
Narrative)
65: R43 Loss Per Share Applicable to Common Stockholders HTML 42K
(Details)
66: R44 Loss Per Share Applicable to Common Stockholders HTML 29K
(Details Narrative)
67: R45 Intangible Assets (Details) HTML 37K
68: R46 Intangible Assets (Details 1) HTML 42K
69: R47 Intangible Assets (Details Narrative) HTML 29K
70: R48 Leasehold Improvements and Equipment (Details) HTML 46K
71: R49 Leasehold Improvements and Equipment (Details HTML 34K
Narrative)
72: R50 Capitalized Lease Obligations (Details) HTML 43K
73: R51 Capitalized Lease Obligations (Details Narrative) HTML 28K
74: R52 Line of Credit (Details Narrative) HTML 30K
75: R53 Income Taxes (Details) HTML 51K
76: R54 Income Taxes (Details 1) HTML 67K
77: R55 Income Taxes (Details Narrative) HTML 35K
78: R56 Related Party Transactions (Details 1) HTML 36K
79: R57 Related Party Transactions (Details 2) HTML 62K
80: R58 Related Party Transactions (Details Narrative) HTML 29K
81: R59 Contract Assets and Contract Liabilities (Details) HTML 56K
82: R60 Discontinued Operations (Details) HTML 62K
83: R61 Discontinued Operations (Details 1) HTML 47K
84: R62 Discontinued Operations (Details 2) HTML 33K
85: R63 Share-Based Compensation (Details) HTML 40K
86: R64 Share-Based Compensation (Details 1) HTML 76K
87: R65 Share-Based Compensation (Details 2) HTML 72K
88: R66 Share-Based Compensation (Details 3) HTML 73K
89: R67 Share-Based Compensation (Details 4) HTML 52K
90: R68 Share-Based Compensation (Details Narrative) HTML 42K
91: R69 Warrants (Details) HTML 49K
92: R70 Commitments and Contingencies (Details) HTML 45K
93: R71 Commitments and Contingencies (Details 1) HTML 29K
94: R72 Commitments and Contingencies (Details 2) HTML 38K
95: R73 Commitments and Contingencies (Details Narrative) HTML 53K
96: R74 Business Segmentation and Geographical HTML 67K
Distribution (Details)
97: R75 Business Segmentation and Geographical HTML 49K
Distribution (Details 1)
98: R76 Business Segmentation and Geographical HTML 46K
Distribution (Details 2)
99: R77 Business Segmentation and Geographical HTML 32K
Distribution (Details Narrative)
100: R78 Other Expense (Details Narrative) HTML 30K
102: XML IDEA XML File -- Filing Summary XML 173K
101: EXCEL IDEA Workbook of Financial Reports XLSX 92K
17: EX-101.INS XBRL Instance -- cdxc-20181231 XML 1.61M
19: EX-101.CAL XBRL Calculations -- cdxc-20181231_cal XML 168K
20: EX-101.DEF XBRL Definitions -- cdxc-20181231_def XML 439K
21: EX-101.LAB XBRL Labels -- cdxc-20181231_lab XML 1.25M
22: EX-101.PRE XBRL Presentations -- cdxc-20181231_pre XML 869K
18: EX-101.SCH XBRL Schema -- cdxc-20181231 XSD 254K
103: ZIP XBRL Zipped Folder -- 0001654954-19-002395-xbrl Zip 147K
RE:
Offer of Employment as Chief Scientific Officer (“CSO”)
and SVP of Innovation
Dear
Matthew,
ChromaDex, Inc., a
subsidiary of ChromaDex, Corp., is pleased to extend you an offer
of full-time employment for the position of CSO and SVP of
Innovation at our Los Angeles facility. This position will report
to Rob Fried, CEO.
If you
accept this offer, your employment will be “at-will.”
This means that either you or the company can end the employment
relationship at any time, for any reason, without notice. Due to
the nature of this position, this offer is contingent upon a full
background check.
If you
accept this offer, your employment will commence on or about
November 5, 2018. Your salary will be two hundred thousand dollars
($200,000) per year and paid biweekly. You will also be eligible
for up to a fifty percent (50%) annual bonus of earned salary based
on accomplishment of objectives which will be discussed with you at
a later date.
In
addition, you will be awarded a one-time initial grant of an option
to purchase three hundred, fifty thousand (350,000) shares of
ChromaDex common stock, at an exercise price reflecting the market
price of ChromaDex common stock on the date of the grant, with
one-third of the shares vesting on the one-year anniversary and the
remaining shares vesting in a series of 24 equal monthly
installments thereafter.
ChromaDex offers
paid time off (PTO) and other company benefits to eligible
employees upon completion of the introductory period as outlined in
the Employee Handbook. You will be eligible for 21 days of PTO per
year accrued on a biweekly basis, pursuant to ChromaDex’s
standard PTO policy for executives, including a waiting-time
period.
By
assuming this full-time role, the current consultant agreement in
place between you and ChromaDex will terminate as of November 4,2018. Additionally, by assuming this full-time role, your position
on the ChromaDex Scientific Advisory Board will also terminate as
of November 4, 2018, including any compensation and/or benefits
provided pursuant to that position.
If you
accept this offer of employment, please sign return a copy of this
letter back to Jordan Gropack at JordanG@chromadex.com
as soon as possible.
For any
questions pertaining to this offer of employment, please feel free
to contact Jordan or myself.
Respectfully,
/s/ Rob
Fried
Rob
Fried
CEO
ChromaDex
I
understand and agree that if I accept the offer of employment with
ChromaDex, that I will be an “at-will” employee, which
means that either I or the company can terminate the employment
relationship at any time, with or without notice, reason, or
cause.
Signature:
/s/ Matthew
Roberts
Date:
Oct 31,
2018
Original: Human Resources
cc:
Manager/Supervisor
-1-
Dates Referenced Herein and Documents Incorporated by Reference
